cached image

Peter Davies, PhD - Publications

Pathology and Neuroscience Albert Einstein College of Medicine, New York, New York, United States 
Alzheimer's, Apoptosis, Amyloid, Phosphorylation

147 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Alpaugh M, Masnata M, de Rus Jacquet A, Lepinay E, Denis HL, Saint-Pierre M, Davies P, Planel E, Cicchetti F. Passive immunization against phosphorylated tau improves features of Huntington's disease pathology. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 35051614 DOI: 10.1016/j.ymthe.2022.01.020  0.317
2020 Wesseling H, Mair W, Kumar M, Schlaffner CN, Tang S, Beerepoot P, Fatou B, Guise AJ, Cheng L, Takeda S, Muntel J, Rotunno MS, Dujardin S, Davies P, Kosik KS, et al. Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer's Disease. Cell. PMID 33188775 DOI: 10.1016/j.cell.2020.10.029  0.544
2020 Goodwin MS, Sinyavskaya O, Burg F, O'Neal V, Ceballos-Diaz C, Cruz PE, Lewis J, Giasson BI, Davies P, Golde TE, Levites Y. Anti-tau scFvs Targeted to the Cytoplasm or Secretory Pathway Variably Modify Pathology and Neurodegenerative Phenotypes. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 33128896 DOI: 10.1016/j.ymthe.2020.10.007  0.306
2020 Xia Y, Prokop S, Gorion KM, Kim JD, Sorrentino ZA, Bell BM, Manaois AN, Chakrabarty P, Davies P, Giasson BI. Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies. Acta Neuropathologica Communications. 8: 88. PMID 32571418 DOI: 10.1186/S40478-020-00967-W  0.344
2019 Davidowitz EJ, Krishnamurthy PK, Lopez P, Jimenez H, Adrien L, Davies P, Moe JG. In Vivo Validation of a Small Molecule Inhibitor of Tau Self-Association in htau Mice. Journal of Alzheimer's Disease : Jad. PMID 31771053 DOI: 10.3233/JAD-190465  0.307
2017 Rubenstein R, Chang B, Grinkina N, Drummond E, Davies P, Ruditzky M, Sharma D, Wang K, Wisniewski T. Tau phosphorylation induced by severe closed head traumatic brain injury is linked to the cellular prion protein. Acta Neuropathologica Communications. 5: 30. PMID 28420443 DOI: 10.1186/S40478-017-0435-7  0.305
2017 Freudenberg-Hua Y, Li W, Ben-Avraham D, Koppel J, Germer S, Darnell R, Barzilai N, Freudenberg J, Atzmon G, Davies P. [P3-118]: INCREASED BURDEN OF RARE LOSS-OF-FUNCTION VARIANTS IN ALZHEIMER's DISEASE PATIENTS COMPARED TO CENTENARIANS Alzheimer's & Dementia. 13: P980-P980. DOI: 10.1016/J.Jalz.2017.06.1329  0.329
2016 Mead E, Kestoras D, Gibson Y, Hamilton L, Goodson R, Jones S, Eversden S, Davies P, O'Neill M, Hutton M, Szekeres P, Wolak J. Halting of Caspase Activity Protects Tau from MC1-Conformational Change and Aggregation. Journal of Alzheimer's Disease : Jad. PMID 27589517 DOI: 10.3233/Jad-150960  0.581
2016 Fu H, Hussaini SA, Wegmann S, Profaci C, Daniels JD, Herman M, Emrani S, Figueroa HY, Hyman BT, Davies P, Duff KE. 3D Visualization of the Temporal and Spatial Spread of Tau Pathology Reveals Extensive Sites of Tau Accumulation Associated with Neuronal Loss and Recognition Memory Deficit in Aged Tau Transgenic Mice. Plos One. 11: e0159463. PMID 27466814 DOI: 10.1371/Journal.Pone.0159463  0.582
2016 Domise M, Didier S, Marinangeli C, Zhao H, Chandakkar P, Buée L, Viollet B, Davies P, Marambaud P, Vingtdeux V. AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo. Scientific Reports. 6: 26758. PMID 27230293 DOI: 10.1038/Srep26758  0.45
2016 Gomar JJ, Conejero-Goldberg C, Davies P, Goldberg TE. Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 26967213 DOI: 10.3233/JAD-150937  0.324
2015 Rubenstein R, Chang B, Petersen R, Chiu A, Davies P. T-Tau and P-Tau in Brain and Blood from Natural and Experimental Prion Diseases. Plos One. 10: e0143103. PMID 26630676 DOI: 10.1371/Journal.Pone.0143103  0.376
2015 d'Abramo C, Acker CM, Schachter JB, Terracina G, Wang X, Forest SK, Davies P. Detecting tau in serum of transgenic animal models after tau immunotherapy treatment. Neurobiology of Aging. PMID 26508157 DOI: 10.1016/J.Neurobiolaging.2015.09.017  0.777
2015 Spiegel J, Pirraglia E, Li Y, Tsui W, Glodzik L, Osorio RS, Saint Louis LA, Randall C, Butler T, Xu J, Zinkowski RP, Zetterberg H, Fortea J, Fossati S, Wisniewski T, ... Davies P, et al. Greater Specificity for Cerebrospinal Fluid P-tau231 over P-tau181 in the Differentiation of Healthy Controls from Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 26444757 DOI: 10.3233/Jad-150167  0.368
2015 Sottejeau Y, Bretteville A, Cantrelle FX, Malmanche N, Demiaute F, Mendes T, Delay C, Alves Dos Alves H, Flaig A, Davies P, Dourlen P, Dermaut B, Laporte J, Amouyel P, Lippens G, et al. Tau phosphorylation regulates the interaction between BIN1's SH3 domain and Tau's proline-rich domain. Acta Neuropathologica Communications. 3: 58. PMID 26395440 DOI: 10.1186/S40478-015-0237-8  0.429
2014 Koppel J, Sunday S, Goldberg TE, Davies P, Christen E, Greenwald BS. Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory: findings from the Alzheimer's Disease Neuroimaging Initiative. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 22: 698-707. PMID 23672944 DOI: 10.1016/J.Jagp.2012.10.028  0.385
2013 Koppel J, Sunday S, Buthorn J, Goldberg T, Davies P, Greenwald B. Elevated CSF Tau is associated with psychosis in Alzheimer's disease. The American Journal of Psychiatry. 170: 1212-3. PMID 24084821 DOI: 10.1176/Appi.Ajp.2013.13040466  0.409
2013 Cavallini A, Brewerton S, Bell A, Sargent S, Glover S, Hardy C, Moore R, Calley J, Ramachandran D, Poidinger M, Karran E, Davies P, Hutton M, Szekeres P, Bose S. An unbiased approach to identifying tau kinases that phosphorylate tau at sites associated with Alzheimer disease. The Journal of Biological Chemistry. 288: 23331-47. PMID 23798682 DOI: 10.1074/jbc.M113.463984  0.64
2013 Dreses-Werringloer U, Vingtdeux V, Zhao H, Chandakkar P, Davies P, Marambaud P. CALHM1 controls the Ca²⁺-dependent MEK, ERK, RSK and MSK signaling cascade in neurons. Journal of Cell Science. 126: 1199-206. PMID 23345406 DOI: 10.1242/jcs.117135  0.31
2013 Forest SK, Acker CM, d'Abramo C, Davies P. Methods for measuring tau pathology in transgenic mouse models. Journal of Alzheimer's Disease : Jad. 33: 463-71. PMID 22976073 DOI: 10.3233/Jad-2012-121354  0.783
2013 Acker CM, Forest SK, Zinkowski R, Davies P, d'Abramo C. Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models. Neurobiology of Aging. 34: 338-50. PMID 22727277 DOI: 10.1016/J.Jalz.2012.05.1222  0.801
2012 Dai M, Freeman B, Shikani HJ, Bruno FP, Collado JE, Macias R, Reznik SE, Davies P, Spray DC, Tanowitz HB, Weiss LM, Desruisseaux MS. Altered regulation of Akt signaling with murine cerebral malaria, effects on long-term neuro-cognitive function, restoration with lithium treatment. Plos One. 7: e44117. PMID 23082110 DOI: 10.1371/Journal.Pone.0044117  0.308
2012 Gordon ML, Kingsley PB, Goldberg TE, Koppel J, Christen E, Keehlisen L, Kohn N, Davies P. An Open-Label Exploratory Study with Memantine: Correlation between Proton Magnetic Resonance Spectroscopy and Cognition in Patients with Mild to Moderate Alzheimer's Disease. Dementia and Geriatric Cognitive Disorders Extra. 2: 312-20. PMID 22962555 DOI: 10.1159/000341604  0.315
2012 Schlatterer SD, Suh HS, Conejero-Goldberg C, Chen S, Acker CM, Lee SC, Davies P. Neuronal c-Abl activation leads to induction of cell cycle and interferon signaling pathways. Journal of Neuroinflammation. 9: 208. PMID 22938163 DOI: 10.1186/1742-2094-9-208  0.777
2012 Weinger JG, Davies P, Acker CM, Brosnan CF, Tsiperson V, Bayewitz A, Shafit-Zagardo B. Mice devoid of Tau have increased susceptibility to neuronal damage in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. Journal of Neuropathology and Experimental Neurology. 71: 422-33. PMID 22487860 DOI: 10.1097/Nen.0B013E3182540D2E  0.386
2012 Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, Duyckaerts C, Frosch MP, Haroutunian V, Hof PR, Hulette CM, et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. Journal of Neuropathology and Experimental Neurology. 71: 362-81. PMID 22487856 DOI: 10.1097/Nen.0B013E31825018F7  0.655
2012 Capiralla H, Vingtdeux V, Zhao H, Sankowski R, Al-Abed Y, Davies P, Marambaud P. Resveratrol mitigates lipopolysaccharide- and Aβ-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade. Journal of Neurochemistry. 120: 461-72. PMID 22118570 DOI: 10.1111/J.1471-4159.2011.07594.X  0.316
2012 Chapuis J, Vingtdeux V, Capiralla H, Davies P, Marambaud P. Gas1 interferes with AβPP trafficking by facilitating the accumulation of immature AβPP in endoplasmic reticulum-associated raft subdomains. Journal of Alzheimer's Disease : Jad. 28: 127-35. PMID 21971401 DOI: 10.3233/JAD-2011-110434  0.312
2012 Forest S, Acker C, Davies P. P3-023: Quantitative methods for evaluation of tau pathology Alzheimer's & Dementia. 8: P462-P462. DOI: 10.1016/J.Jalz.2012.05.1241  0.749
2011 Chai X, Wu S, Murray TK, Kinley R, Cella CV, Sims H, Buckner N, Hanmer J, Davies P, O'Neill MJ, Hutton ML, Citron M. Passive immunization with anti-Tau antibodies in two transgenic models: reduction of Tau pathology and delay of disease progression. The Journal of Biological Chemistry. 286: 34457-67. PMID 21841002 DOI: 10.1074/jbc.M111.229633  0.611
2011 Schlatterer SD, Acker CM, Davies P. c-Abl in neurodegenerative disease. Journal of Molecular Neuroscience : Mn. 45: 445-52. PMID 21728062 DOI: 10.1007/S12031-011-9588-1  0.779
2011 Boutajangout A, Ingadottir J, Davies P, Sigurdsson EM. Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain. Journal of Neurochemistry. 118: 658-67. PMID 21644996 DOI: 10.1111/j.1471-4159.2011.07337.x  0.306
2011 Koppel J, Campagne F, Vingtdeux V, Dreses-Werringloer U, Ewers M, Rujescu D, Hampel H, Gordon ML, Christen E, Chapuis J, Greenwald BS, Davies P, Marambaud P. CALHM1 P86L polymorphism modulates CSF Aβ levels in cognitively healthy individuals at risk for Alzheimer's disease. Molecular Medicine (Cambridge, Mass.). 17: 974-9. PMID 21629967 DOI: 10.2119/molmed.2011.00154  0.369
2011 Schlatterer SD, Tremblay MA, Acker CM, Davies P. Neuronal c-Abl overexpression leads to neuronal loss and neuroinflammation in the mouse forebrain. Journal of Alzheimer's Disease : Jad. 25: 119-33. PMID 21368377 DOI: 10.3233/Jad-2011-102025  0.793
2011 Chapuis J, Vingtdeux V, Campagne F, Davies P, Marambaud P. Growth arrest-specific 1 binds to and controls the maturation and processing of the amyloid-beta precursor protein. Human Molecular Genetics. 20: 2026-36. PMID 21357679 DOI: 10.1093/hmg/ddr085  0.363
2011 Vingtdeux V, Davies P, Dickson DW, Marambaud P. AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies. Acta Neuropathologica. 121: 337-49. PMID 20957377 DOI: 10.1007/S00401-010-0759-X  0.329
2011 Schlatterer S, Acker C, Davies P. P3-040: Elevation of inflammatory markers precedes development of neuroinflammatory pathology and neuronal loss in mice expressing constitutively active c-Abl in forebrain Alzheimer's & Dementia. 7: S527-S527. DOI: 10.1016/J.Jalz.2011.05.1479  0.762
2010 Vingtdeux V, Chandakkar P, Zhao H, d'Abramo C, Davies P, Marambaud P. Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-β peptide degradation. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 25: 219-31. PMID 20852062 DOI: 10.1096/fj.10-167361  0.322
2010 Giliberto L, d'Abramo C, Acker CM, Davies P, D'Adamio L. Transgenic expression of the amyloid-beta precursor protein-intracellular domain does not induce Alzheimer's Disease-like traits in vivo. Plos One. 5: e11609. PMID 20661273 DOI: 10.1371/Journal.Pone.0011609  0.363
2010 Tremblay MA, Acker CM, Davies P. Tau phosphorylated at tyrosine 394 is found in Alzheimer's disease tangles and can be a product of the Abl-related kinase, Arg. Journal of Alzheimer's Disease : Jad. 19: 721-33. PMID 20110615 DOI: 10.3233/JAD-2010-1271  0.43
2010 Rojo LE, Alzate-Morales J, Saavedra IN, Davies P, Maccioni RB. Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 19: 573-89. PMID 20110603 DOI: 10.3233/JAD-2010-1262  0.408
2010 Vingtdeux V, Giliberto L, Zhao H, Chandakkar P, Wu Q, Simon JE, Janle EM, Lobo J, Ferruzzi MG, Davies P, Marambaud P. AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. The Journal of Biological Chemistry. 285: 9100-13. PMID 20080969 DOI: 10.1074/Jbc.M109.060061  0.362
2010 Szekeres PG, Glover SJ, Lakics V, Cella CV, Purcell R, Murray TK, Cavallini A, Lavenir I, Goedert M, Davies P, Hutton ML, O'Neill MJ. Dramatic increases in phosphorylation of tau only on specific epitopes correlates with decline in motor function in aged P301S mice Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.901  0.346
2010 Goldgaber D, Davies P, Gambetti P, Walker LC, Friedland RP, White LR, Piccardo P, Asher DM. P1-263: Transmission of Alzheimer amyloidosis to chimpanzees and monkeys: Revisited Alzheimer's & Dementia. 6: S250-S250. DOI: 10.1016/J.Jalz.2010.05.815  0.333
2010 Schlatterer SD, Tremblay MA, Acker CM, Davies P. P1-160: Neurodegeneration as a consequence of expression of active c-abl in the adult mouse brain Alzheimer's & Dementia. 6: S220-S220. DOI: 10.1016/J.Jalz.2010.05.710  0.761
2010 Conejero-Goldberg C, Hyde TM, Chen S, Dreses-Werringloer U, Herman MM, Kleinman JE, Davies P, Goldberg TE. Molecular signatures in post mortem brain tissue of individuals at high risk for Alzheimer's disease Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.619  0.328
2009 Polydoro M, Acker CM, Duff K, Castillo PE, Davies P. Age-dependent impairment of cognitive and synaptic function in the htau mouse model of tau pathology. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 10741-9. PMID 19710325 DOI: 10.1523/Jneurosci.1065-09.2009  0.764
2009 Hu S, Begum AN, Jones MR, Oh MS, Beech WK, Beech BH, Yang F, Chen P, Ubeda OJ, Kim PC, Davies P, Ma Q, Cole GM, Frautschy SA. GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals. Neurobiology of Disease. 33: 193-206. PMID 19038340 DOI: 10.1016/j.nbd.2008.10.007  0.392
2009 Polydoro M, Acker CM, Duff K, Castillo PE, Davies P. O4-03-01: Age-dependent impairment of cognitive and synaptic function in transgenic mouse model of tau pathology (htau mouse) Alzheimer's & Dementia. 5: P153-P154. DOI: 10.1016/J.Jalz.2009.05.531  0.75
2009 Conejero-Goldberg C, Hyde TM, Chen S, Dreses-Werringloer U, Herman M, Kleinman JE, Davies P, Goldberg T. Molecular signature of prodromal Alzheimer's disease: A microarray study in post-mortem cortical tissue Alzheimers & Dementia. 5: 305. DOI: 10.1016/J.Jalz.2009.04.460  0.334
2008 Planel E, Krishnamurthy P, Miyasaka T, Liu L, Herman M, Kumar A, Bretteville A, Figueroa HY, Yu WH, Whittington RA, Davies P, Takashima A, Nixon RA, Duff KE. Anesthesia-induced hyperphosphorylation detaches 3-repeat tau from microtubules without affecting their stability in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 12798-807. PMID 19036972 DOI: 10.1523/Jneurosci.4101-08.2008  0.404
2008 Dreses-Werringloer U, Lambert JC, Vingtdeux V, Zhao H, Vais H, Siebert A, Jain A, Koppel J, Rovelet-Lecrux A, Hannequin D, Pasquier F, Galimberti D, Scarpini E, Mann D, Lendon C, ... ... Davies P, et al. A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk. Cell. 133: 1149-61. PMID 18585350 DOI: 10.1016/J.Cell.2008.05.048  0.331
2008 Espinoza M, de Silva R, Dickson DW, Davies P. Differential incorporation of tau isoforms in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 14: 1-16. PMID 18525123 DOI: 10.3233/Jad-2008-14101  0.427
2008 Crystal HA, Davies P. Toward a plasma marker for Alzheimer disease: some progress, but still a long way to go. Neurology. 70: 586-7. PMID 18285532 DOI: 10.1212/01.wnl.0000299905.05595.68  0.335
2008 Conejero-Goldberg C, Townsend K, Davies P. Effects of cell cycle inhibitors on tau phosphorylation in N2aTau3R cells. Journal of Molecular Neuroscience : Mn. 35: 143-50. PMID 18278567 DOI: 10.1007/s12031-008-9044-z  0.399
2008 Marambaud P, Dreses-Werringloer U, Lambert J, Vingtdeux V, Zhao H, Koppel J, Pasquier F, Mann D, Lendon C, Amouyel P, Foskett JK, Campagne F, Davies P. O4-06-06: The calcium homeostasis modulator CALHM1 controls Abeta levels and Alzheimer's disease risk Alzheimer's & Dementia. 4: T197-T197. DOI: 10.1016/J.Jalz.2008.05.550  0.306
2008 Dreses-Werringloer U, Lambert J, Vingtdeux V, Zhao H, Vais H, Siebert A, Jain A, Koppel J, Pasquier F, Mann D, Lendon C, Amouyel P, Davies P, Foskett JK, Campagne F, et al. P4-245: The Alzheimer's disease susceptibility gene CALHM1 encodes a brain calcium channel Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.2313  0.316
2007 Conejero-Goldberg C, Davies P, Ulloa L. Alpha7 nicotinic acetylcholine receptor: a link between inflammation and neurodegeneration. Neuroscience and Biobehavioral Reviews. 32: 693-706. PMID 18180036 DOI: 10.1016/j.neubiorev.2007.10.007  0.364
2007 Amador-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, Duara R, Graff-Radford NR, Hutton ML, Dickson DW. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Annals of Neurology. 61: 435-45. PMID 17469117 DOI: 10.1002/Ana.21154  0.597
2007 Park KH, Hallows JL, Chakrabarty P, Davies P, Vincent I. Conditional neuronal simian virus 40 T antigen expression induces Alzheimer-like tau and amyloid pathology in mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 2969-78. PMID 17360920 DOI: 10.1523/Jneurosci.0186-07.2007  0.423
2007 Josephs KA, Ahmed Z, Katsuse O, Parisi JF, Boeve BF, Knopman DS, Petersen RC, Davies P, Duara R, Graff-Radford NR, Uitti RJ, Rademakers R, Adamson J, Baker M, Hutton ML, et al. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. Journal of Neuropathology and Experimental Neurology. 66: 142-51. PMID 17278999 DOI: 10.1097/Nen.0B013E31803020Cf  0.524
2007 Haroutunian V, Davies P, Vianna C, Buxbaum JD, Purohit DP. Tau protein abnormalities associated with the progression of alzheimer disease type dementia. Neurobiology of Aging. 28: 1-7. PMID 16343696 DOI: 10.1016/J.Neurobiolaging.2005.11.001  0.423
2006 Davies P. A long trek down the pathways of cell death in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 9: 265-9. PMID 16914865 DOI: 10.3233/JAD-2006-9S329  0.335
2006 Siegel DA, Davies P, Dobrenis K, Huang M. Tomoregulin-2 is found extensively in plaques in Alzheimer's disease brain. Journal of Neurochemistry. 98: 34-44. PMID 16805794 DOI: 10.1111/j.1471-4159.2006.03801.x  0.402
2006 d'Abramo C, Ricciarelli R, Pronzato MA, Davies P. Troglitazone, a peroxisome proliferator-activated receptor-gamma agonist, decreases tau phosphorylation in CHOtau4R cells. Journal of Neurochemistry. 98: 1068-77. PMID 16787414 DOI: 10.1111/j.1471-4159.2006.03931.x  0.399
2006 Herskovits AZ, Davies P. The regulation of tau phosphorylation by PCTAIRE 3: implications for the pathogenesis of Alzheimer's disease. Neurobiology of Disease. 23: 398-408. PMID 16766195 DOI: 10.1016/J.Nbd.2006.04.004  0.816
2006 de Silva R, Lashley T, Strand C, Shiarli AM, Shi J, Tian J, Bailey KL, Davies P, Bigio EH, Arima K, Iseki E, Murayama S, Kretzschmar H, Neumann M, Lippa C, et al. An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies. Acta Neuropathologica. 111: 329-40. PMID 16552612 DOI: 10.1007/S00401-006-0048-X  0.374
2006 Cripps D, Thomas SN, Jeng Y, Yang F, Davies P, Yang AJ. Alzheimer disease-specific conformation of hyperphosphorylated paired helical filament-Tau is polyubiquitinated through Lys-48, Lys-11, and Lys-6 ubiquitin conjugation. The Journal of Biological Chemistry. 281: 10825-38. PMID 16443603 DOI: 10.1074/Jbc.M512786200  0.434
2005 Andorfer C, Acker CM, Kress Y, Hof PR, Duff K, Davies P. Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 5446-54. PMID 15930395 DOI: 10.1523/Jneurosci.4637-04.2005  0.791
2005 Hampel H, Bürger K, Pruessner JC, Zinkowski R, DeBernardis J, Kerkman D, Leinsinger G, Evans AC, Davies P, Möller HJ, Teipel SJ. Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease. Archives of Neurology. 62: 770-3. PMID 15883264 DOI: 10.1001/archneur.62.5.770  0.415
2005 Herskovits AZ, Davies P. Generation and characterization of monoclonal antibodies to human PCTAIRE 3. Hybridoma (2005). 24: 98-105. PMID 15857174 DOI: 10.1089/Hyb.2005.24.98  0.754
2005 Fujino Y, Wang DS, Thomas N, Espinoza M, Davies P, Dickson DW. Increased frequency of argyrophilic grain disease in Alzheimer disease with 4R tau-specific immunohistochemistry. Journal of Neuropathology and Experimental Neurology. 64: 209-14. PMID 15804052 DOI: 10.1093/Jnen/64.3.209  0.385
2005 Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, Raman R, Davies P, Masliah E, Williams DS, Goldstein LS. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science (New York, N.Y.). 307: 1282-8. PMID 15731448 DOI: 10.1126/Science.1105681  0.341
2005 Tchaikovskaya T, Fraifeld V, Urphanishvili T, Andorfer JH, Davies P, Listowsky I. Glutathione S-transferase hGSTM3 and ageing-associated neurodegeneration: relationship to Alzheimer's disease. Mechanisms of Ageing and Development. 126: 309-315. PMID 15621212 DOI: 10.1016/J.Mad.2004.08.029  0.351
2004 Lovell MA, Xiong S, Xie C, Davies P, Markesbery WR. Induction of hyperphosphorylated tau in primary rat cortical neuron cultures mediated by oxidative stress and glycogen synthase kinase-3. Journal of Alzheimer's Disease : Jad. 6: 659-71; discussion 6. PMID 15665406 DOI: 10.3233/Jad-2004-6610  0.376
2004 Yao J, Petanceska SS, Montine TJ, Holtzman DM, Schmidt SD, Parker CA, Callahan MJ, Lipinski WJ, Bisgaier CL, Turner BA, Nixon RA, Martins RN, Ouimet C, Smith JD, Davies P, et al. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits. Journal of Neurochemistry. 90: 1011-8. PMID 15287908 DOI: 10.1111/J.1471-4159.2004.02532.X  0.355
2004 Herskovits AZ, Davies P. Cloning and expression analysis of two novel PCTAIRE 3 transcripts from human brain. Gene. 328: 59-67. PMID 15019984 DOI: 10.1016/J.Gene.2003.12.011  0.734
2004 Hampel H, Buerger K, Zinkowski R, Teipel SJ, Goernitz A, Andreasen N, Sjoegren M, DeBernardis J, Kerkman D, Ishiguro K, Ohno H, Vanmechelen E, Vanderstichele H, McCulloch C, Moller HJ, ... Davies P, et al. Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study. Archives of General Psychiatry. 61: 95-102. PMID 14706948 DOI: 10.1001/archpsyc.61.1.95  0.429
2004 Andorfer CA, Acker CM, Kress Y, Duff K, Davies P. P2-078 Neurofibrillary tangles and cell death in transgenic mice expressing non-mutant human isoforms of TAU Neurobiology of Aging. 25: S246. DOI: 10.1016/S0197-4580(04)80825-X  0.771
2004 de Leon MJ, Santi SD, Zinkowski R, Mehta P, Pratico D, Segal S, Rusinek H, Li J, Tsui W, Louis LS, Clark C, Tarshish C, Lair L, Javier E, Lesbre P, ... ... Davies P, et al. O2-01-01 Biomarkers for Alzheimer's disease improve early diagnosis Neurobiology of Aging. 25: S33-S34. DOI: 10.1016/S0197-4580(04)80111-8  0.317
2003 Ramakrishnan P, Dickson DW, Davies P. Pin1 colocalization with phosphorylated tau in Alzheimer's disease and other tauopathies. Neurobiology of Disease. 14: 251-64. PMID 14572447 DOI: 10.1016/S0969-9961(03)00109-8  0.693
2003 Scheinfeld MH, Ghersi E, Davies P, D'Adamio L. Amyloid beta protein precursor is phosphorylated by JNK-1 independent of, yet facilitated by, JNK-interacting protein (JIP)-1. The Journal of Biological Chemistry. 278: 42058-63. PMID 12917434 DOI: 10.1074/Jbc.M304853200  0.388
2003 Hogg M, Grujic ZM, Baker M, Demirci S, Guillozet AL, Sweet AP, Herzog LL, Weintraub S, Mesulam MM, LaPointe NE, Gamblin TC, Berry RW, Binder LI, de Silva R, Lees A, ... ... Davies P, et al. The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy. Acta Neuropathologica. 106: 323-36. PMID 12883828 DOI: 10.1007/S00401-003-0734-X  0.578
2003 Andorfer C, Kress Y, Espinoza M, de Silva R, Tucker KL, Barde YA, Duff K, Davies P. Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. Journal of Neurochemistry. 86: 582-90. PMID 12859672 DOI: 10.1046/J.1471-4159.2003.01879.X  0.808
2003 Tandon A, Yu H, Wang L, Rogaeva E, Sato C, Chishti MA, Kawarai T, Hasegawa H, Chen F, Davies P, Fraser PE, Westaway D, St George-Hyslop PH. Brain levels of CDK5 activator p25 are not increased in Alzheimer's or other neurodegenerative diseases with neurofibrillary tangles. Journal of Neurochemistry. 86: 572-81. PMID 12859671 DOI: 10.1046/J.1471-4159.2003.01865.X  0.385
2003 Noble W, Olm V, Takata K, Casey E, Mary O, Meyerson J, Gaynor K, LaFrancois J, Wang L, Kondo T, Davies P, Burns M, Veeranna, Nixon R, Dickson D, et al. Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron. 38: 555-65. PMID 12765608 DOI: 10.1016/S0896-6273(03)00259-9  0.443
2003 Ishizawa T, Mattila P, Davies P, Wang D, Dickson DW. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies. Journal of Neuropathology and Experimental Neurology. 62: 389-97. PMID 12722831 DOI: 10.1093/Jnen/62.4.389  0.397
2002 de Leon MJ, Segal S, Tarshish CY, DeSanti S, Zinkowski R, Mehta PD, Convit A, Caraos C, Rusinek H, Tsui W, Saint Louis LA, DeBernardis J, Kerkman D, Qadri F, Gary A, ... ... Davies P, et al. Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairment. Neuroscience Letters. 333: 183-6. PMID 12429378 DOI: 10.1016/S0304-3940(02)01038-8  0.404
2002 Buerger K, Zinkowski R, Teipel SJ, Tapiola T, Arai H, Blennow K, Andreasen N, Hofmann-Kiefer K, DeBernardis J, Kerkman D, McCulloch C, Kohnken R, Padberg F, Pirttilä T, Schapiro MB, ... ... Davies P, et al. Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231. Archives of Neurology. 59: 1267-72. PMID 12164722 DOI: 10.1001/Archneur.59.8.1267  0.427
2002 Conrad C, Vianna C, Freeman M, Davies P. A polymorphic gene nested within an intron of the tau gene: implications for Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 99: 7751-6. PMID 12032355 DOI: 10.1073/pnas.112194599  0.344
2001 Parvathy S, Davies P, Haroutunian V, Purohit DP, Davis KL, Mohs RC, Park H, Moran TM, Chan JY, Buxbaum JD. Correlation between Abetax-40-, Abetax-42-, and Abetax-43-containing amyloid plaques and cognitive decline. Archives of Neurology. 58: 2025-32. PMID 11735776 DOI: 10.1001/Archneur.58.12.2025  0.35
2001 Dranovsky A, Vincent I, Gregori L, Schwarzman A, Colflesh D, Enghild J, Strittmatter W, Davies P, Goldgaber D. Cdc2 phosphorylation of nucleolin demarcates mitotic stages and Alzheimer's disease pathology. Neurobiology of Aging. 22: 517-28. PMID 11445251 DOI: 10.1016/S0197-4580(00)00248-7  0.406
2001 Bigio EH, Lipton AM, Yen SH, Hutton ML, Baker M, Nacharaju P, White CL, Davies P, Lin W, Dickson DW. Frontal lobe dementia with novel tauopathy: sporadic multiple system tauopathy with dementia. Journal of Neuropathology and Experimental Neurology. 60: 328-41. PMID 11305868 DOI: 10.1093/Jnen/60.4.328  0.615
2000 Weaver CL, Espinoza M, Kress Y, Davies P. Conformational change as one of the earliest alterations of tau in Alzheimer's disease. Neurobiology of Aging. 21: 719-27. PMID 11016541 DOI: 10.1016/S0197-4580(00)00157-3  0.757
2000 Andorfer CA, Davies P. PKA phosphorylations on tau: developmental studies in the mouse. Developmental Neuroscience. 22: 303-9. PMID 10965152 DOI: 10.1159/000017454  0.789
2000 Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, Van Slegtenhorst M, Gwinn-Hardy K, Paul Murphy M, Baker M, Yu X, Duff K, Hardy J, Corral A, Lin WL, Yen SH, ... ... Davies P, et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nature Genetics. 25: 402-5. PMID 10932182 DOI: 10.1038/78078  0.63
2000 Crystal HA, Dickson D, Davies P, Masur D, Grober E, Lipton RB. The relative frequency of 'dementia of unknown etiology' increases with age and is nearly 50% in nonagenarians Archives of Neurology. 57: 713-719. PMID 10815138 DOI: 10.1001/Archneur.57.5.713  0.338
2000 Duff K, Knight H, Refolo LM, Sanders S, Yu X, Picciano M, Malester B, Hutton M, Adamson J, Goedert M, Burki K, Davies P. Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes. Neurobiology of Disease. 7: 87-98. PMID 10783293 DOI: 10.1006/Nbdi.1999.0279  0.472
2000 Näslund J, Haroutunian V, Mohs R, Davis KL, Davies P, Greengard P, Buxbaum JD. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. Jama. 283: 1571-7. PMID 10735393 DOI: 10.1001/Jama.283.12.1571  0.38
2000 Davies P, Andorfer C, Weaver CL, Stahl M, Espinzona M, DeBernardis J. APP and tau phosphorylation in early Alzheimer's disease Neurobiology of Aging. 21: 210-211. DOI: 10.1016/S0197-4580(00)83276-5  0.807
2000 Bussiere T, Wicinski BA, Lin GI, Perl DP, Davies P, Nixon RA, Morrison JH, Hof PR. Stereologic analysis of vulnerable neocortical neurons in normal aging and Alzheimer's disease Neurobiology of Aging. 21: 24-25. DOI: 10.1016/S0197-4580(00)82787-6  0.354
2000 Duff K, Refolo LM, Hutton M, Davies P. Tau pathobiology in transgenic mouse models Neurobiology of Aging. 21: 76. DOI: 10.1016/S0197-4580(00)82565-8  0.472
2000 Lewis J, Davies P, Yen S, Dickson DW, Hutton M. Neurofibrillary tangles, neuronal loss, and severe motor changes develop in transgenic mice expressing tau (4R0N) with the frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17) mutation P301L Neurobiology of Aging. 21: 59. DOI: 10.1016/S0197-4580(00)82491-4  0.588
1999 Jicha GA, Weaver C, Lane E, Vianna C, Kress Y, Rockwood J, Davies P. cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 7486-94. PMID 10460255 DOI: 10.1523/Jneurosci.19-17-07486.1999  0.785
1999 Lu PJ, Wulf G, Zhou XZ, Davies P, Lu KP. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature. 399: 784-8. PMID 10391244 DOI: 10.1038/21650  0.437
1999 Jicha GA, Berenfeld B, Davies P. Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer's disease. Journal of Neuroscience Research. 55: 713-23. PMID 10220112 DOI: 10.1002/(Sici)1097-4547(19990315)55:6<713::Aid-Jnr6>3.0.Co;2-G  0.642
1999 Houlden H, Rizzu P, Stevens M, de Knijff P, van Duijn CM, van Swieten JC, Heutink P, Perez-Tur J, Thomas V, Baker M, Morris H, Rossor M, Jannsen JC, Petersen RC, Dodd P, ... ... Davies P, et al. Apolipoprotein E genotype does not affect the age of onset of dementia in families with defined tau mutations. Neuroscience Letters. 260: 193-5. PMID 10076900 DOI: 10.1016/S0304-3940(98)00931-8  0.363
1999 Jicha GA, Rockwood JM, Berenfeld B, Hutton M, Davies P. Altered conformation of recombinant frontotemporal dementia-17 mutant tau proteins. Neuroscience Letters. 260: 153-6. PMID 10076890 DOI: 10.1016/S0304-3940(98)00980-X  0.693
1998 Anderton BH, Callahan L, Coleman P, Davies P, Flood D, Jicha GA, Ohm T, Weaver C. Dendritic changes in Alzheimer's disease and factors that may underlie these changes Progress in Neurobiology. 55: 595-609. PMID 9670220 DOI: 10.1016/S0301-0082(98)00022-7  0.759
1998 Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A, Hackett J, Adamson J, Lincoln S, Dickson D, Davies P, et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 393: 702-5. PMID 9641683 DOI: 10.1038/31508  0.587
1998 Davies P, Resnick J, Resnick B, Gilman S, Growdon JH, Khachaturian ZS, Radebaugh TS, Roses AD, Selkoe DJ, Trojanowski JQ, Blass JP, Gibson GE, Sheu KFR, Blennow K, Delacourte A, et al. Consensus report of the working group on: 'Molecular and biochemical markers of Alzheimer's disease' Neurobiology of Aging. 19: 109-116. PMID 9558143 DOI: 10.1016/S0197-4580(98)00022-0  0.545
1997 Jicha GA, Lane E, Vincent I, Otvos L, Hoffmann R, Davies P. A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease. Journal of Neurochemistry. 69: 2087-95. PMID 9349554 DOI: 10.1046/J.1471-4159.1997.69052087.X  0.681
1997 Mizukami K, Ikonomovic MD, Grayson DR, Rubin RT, Warde D, Sheffield R, Hamilton RL, Davies P, Armstrong DM. Immunohistochemical study of GABA(A) receptor beta2/3 subunits in the hippocampal formation of aged brains with Alzheimer-related neuropathologic changes. Experimental Neurology. 147: 333-45. PMID 9344558 DOI: 10.1006/Exnr.1997.6591  0.303
1997 Ikonomovic MD, Mizukami K, Davies P, Hamilton R, Sheffield R, Armstrong DM. The loss of GluR2(3) immunoreactivity precedes neurofibrillary tangle formation in the entorhinal cortex and hippocampus of Alzheimer brains. Journal of Neuropathology and Experimental Neurology. 56: 1018-27. PMID 9291943 DOI: 10.1097/00005072-199709000-00007  0.333
1997 Jicha GA, Bowser R, Kazam IG, Davies P. Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. Journal of Neuroscience Research. 48: 128-32. PMID 9130141 DOI: 10.1002/(Sici)1097-4547(19970415)48:2<128::Aid-Jnr5>3.0.Co;2-E  0.74
1997 Shafit-Zagardo B, Kalcheva N, Dickson D, Davies P, Kress Y. Distribution and subcellular localization of high-molecular-weight microtubule-associated protein-2 expressing exon 8 in brain and spinal cord. Journal of Neurochemistry. 68: 862-73. PMID 9003079 DOI: 10.1046/J.1471-4159.1997.68020862.X  0.303
1996 Schoonover S, Davies P, Bowser R. Immunolocalization and redistribution of the FAC1 protein in Alzheimer's disease. Journal of Neuropathology and Experimental Neurology. 55: 444-55. PMID 8786404 DOI: 10.1097/00005072-199604000-00007  0.649
1996 Ksiezak-Reding H, Leibowitz RL, Bowser R, Davies P. Binding of Alz 50 depends on Phe8 in tau synthetic peptides and varies between native and denatured tau proteins. Brain Research. 697: 63-75. PMID 8593596 DOI: 10.1016/0006-8993(95)00785-O  0.538
1996 Edelmann W, Zervas M, Costello P, Roback L, Fischer I, Hammarback JA, Cowan N, Davies P, Wainer B, Kucherlapati R. Neuronal abnormalities in microtubule-associated protein 1B mutant mice. Proceedings of the National Academy of Sciences of the United States of America. 93: 1270-5. PMID 8577753 DOI: 10.1073/Pnas.93.3.1270  0.354
1995 Bowser R, Giambrone A, Davies P. FAC1, a novel gene identified with the monoclonal antibody Alz50, is developmentally regulated in human brain. Developmental Neuroscience. 17: 20-37. PMID 7621746 DOI: 10.1159/000111270  0.538
1995 Dickson DW, Crystal HA, Bevona C, Honer W, Vincent I, Davies P. Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiology of Aging. 16: 285-98; discussion 2. PMID 7566338 DOI: 10.1016/0197-4580(95)00013-5  0.352
1995 Bowser R, Giambrone A, Davies P. FAC1, a Novel Gene Identified with the Monoclonal Antibody Alz50, Is Developmentally Regulated in Human Brain (Part 2 of 2) Developmental Neuroscience. 17: 30-37. DOI: 10.1159/000315743  0.538
1993 Arias C, Sharma N, Davies P, Shafit-Zagardo B. Okadaic acid induces early changes in microtubule-associated protein 2 and tau phosphorylation prior to neurodegeneration in cultured cortical neurons. Journal of Neurochemistry. 61: 673-82. PMID 8336148 DOI: 10.1111/j.1471-4159.1993.tb02172.x  0.382
1993 Rye DB, Leverenz J, Greenberg SG, Davies P, Saper CB. The distribution of Alz-50 immunoreactivity in the normal human brain. Neuroscience. 56: 109-27. PMID 8232910 DOI: 10.1016/0306-4522(93)90567-Y  0.39
1992 Honer WG, Dickson DW, Gleeson J, Davies P. Regional synaptic pathology in Alzheimer's disease Neurobiology of Aging. 13: 375-382. PMID 1625766 DOI: 10.1016/0197-4580(92)90111-A  0.365
1992 Licameli V, Mattiace LA, Erlichman J, Davies P, Dickson D, Shafit-Zagardo B. Regional localization of the regulatory subunit (RII beta) of the type II cAMP-dependent protein kinase in human brain. Brain Research. 578: 61-8. PMID 1511290 DOI: 10.1016/0006-8993(92)90230-7  0.359
1992 Dickson DW, Crystal HA, Mattiace LA, Masur DM, Blau AD, Davies P, Yen SH, Aronson MK. Identification of normal and pathological aging in prospectively studied nondemented elderly humans Neurobiology of Aging. 13: 179-189. PMID 1311804 DOI: 10.1016/0197-4580(92)90027-U  0.371
1990 Jagust WJ, Davies P, Tiller-Borcich JK, Reed BR. Focal Alzheimer's disease. Neurology. 40: 14-9. PMID 2296360 DOI: 10.1212/WNL.40.1.14  0.354
1990 Mattiace LA, Davies P, Yen SH, Dickson DW. Microglia in cerebellar plaques in Alzheimer's disease Acta Neuropathologica. 80: 493-498. PMID 2251906 DOI: 10.1007/Bf00294609  0.368
1990 Ghanbari HA, Miller BE, Haigler HJ, Arato M, Bissette G, Davies P, Nemeroff CB, Perry EK, Perry R, Ravid R. Biochemical assay of Alzheimer's disease--associated protein(s) in human brain tissue. A clinical study. Jama. 263: 2907-10. PMID 2187102 DOI: 10.1001/Jama.1990.03440210057032  0.384
1988 Hyman BT, Van Hoesen GW, Wolozin BL, Davies P, Kromer LJ, Damasio AR. Alz-50 antibody recognizes Alzheimer-related neuronal changes. Annals of Neurology. 23: 371-9. PMID 3382173 DOI: 10.1002/ana.410230410  0.52
1988 Hansen LA, DeTeresa R, Davies P, Terry RD. Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease. Neurology. 38: 48-54. PMID 3336463 DOI: 10.1212/Wnl.38.1.48  0.504
1988 Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, Renbing X, Peck A. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Annals of Neurology. 23: 138-44. PMID 2897823 DOI: 10.1002/Ana.410230206  0.581
1988 Doebler JA, Markesbery WR, Anthony A, Davies P, Scheff SW, Rhoads RE. Neuronal RNA in relation to Alz-50 immunoreactivity in Alzheimer's disease. Annals of Neurology. 23: 20-4. PMID 2449843 DOI: 10.1002/Ana.410230105  0.346
1987 Dickson DW, Davies P, Mayeux R, Crystal H, Horoupian DS, Thompson A, Goldman JE. Diffuse Lewy body disease. Neuropathological and biochemical studies of six patients. Acta Neuropathologica. 75: 8-15. PMID 3434218 DOI: 10.1007/Bf00686786  0.37
1987 Mehler MF, Horoupian DS, Davies P, Dickson DW. Reduced somatostatin-like immunoreactivity in cerebral cortex in nonfamilial dysphasic dementia. Neurology. 37: 1448-53. PMID 2888051 DOI: 10.1212/Wnl.37.9.1448  0.332
1987 Terry RD, Hansen LA, DeTeresa R, Davies P, Tobias H, Katzman R. Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles. Journal of Neuropathology and Experimental Neurology. 46: 262-8. PMID 2881985 DOI: 10.1097/00005072-198705000-00003  0.504
1987 Dickson DW, Ksiezak-Reding H, Davies P, Yen SH. A monoclonal antibody that recognizes a phosphorylated epitope in Alzheimer neurofibrillary tangles, neurofilaments and tau proteins immunostains granulovacuolar degeneration Acta Neuropathologica. 73: 254-258. PMID 2441560 DOI: 10.1007/Bf00686619  0.424
1986 Dickson DW, Horoupian DS, Thal LJ, Davies P, Walkley S, Terry RD. Klüver-Bucy syndrome and amyotrophic lateral sclerosis: a case report with biochemistry, morphometrics, and Golgi study. Neurology. 36: 1323-9. PMID 3762937 DOI: 10.1212/Wnl.36.10.1323  0.504
1986 Wolozin BL, Pruchnicki A, Dickson DW, Davies P. A neuronal antigen in the brains of Alzheimer patients Science. 232: 648-650. PMID 3083509 DOI: 10.1097/00002093-198701000-00007  0.364
1984 Horoupian DS, Thal L, Katzman R, Terry RD, Davies P, Hirano A, DeTeresa R, Fuld PA, Petito C, Blass J. Dementia and motor neuron disease: morphometric, biochemical, and Golgi studies. Annals of Neurology. 16: 305-13. PMID 6148912 DOI: 10.1002/Ana.410160306  0.504
1982 Fuld PA, Katzman R, Davies P, Terry RD. Intrusions as a sign of Alzheimer dementia: chemical and pathological verification. Annals of Neurology. 11: 155-9. PMID 7073248 DOI: 10.1002/ana.410110208  0.504
1982 Terry RD, Davies P, DeTeresa R, Katzman R. ARE BOTH PLAQUES AND TANGLES REQUIRED TO MAKE IT ALZHEIMERʼS DISEASE? Journal of Neuropathology and Experimental Neurology. 41: 364. DOI: 10.1097/00005072-198205000-00078  0.504
1981 Davies P, Terry RD. Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type. Neurobiology of Aging. 2: 9-14. PMID 6115327 DOI: 10.1016/0197-4580(81)90053-1  0.504
1980 Terry RD, Davies P. Dementia of the Alzheimer type. Annual Review of Neuroscience. 3: 77-95. PMID 6251745 DOI: 10.1146/  0.504
1980 Davies P, Katzman R, Terry RD. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa. Nature. 288: 279-80. PMID 6107862 DOI: 10.1038/288279a0  0.504
1980 Davies P, Kress Y, Terry RD. AUTORADIOGRAPHIC DEMONSTRATION OF MUSCARINIC RECEPTORS IN HUMAN BRAIN Journal of Neuropathology and Experimental Neurology. 39: 348. DOI: 10.1097/00005072-198005000-00043  0.504
Show low-probability matches.